According to Zhitong Finance App, Junshengtai Pharmaceutical-B (02511.HK) announced that on September 1, 2026, the company granted 2,0404,500 share options to 4 grantees in accordance with the 2025 share incentive plan; and 306,700 rewards to 1 grantor, accounting for approximately 0.30% and 0.05% of the total number of shares issued and issued (excluding treasury shares) as of the grant date, respectively.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.